ESR1 and breast cancer: The anti-cancer efficiency of IC diminished in the presence of tamoxifen, whereas the suppression of autophagy augmented its activity—indicating that IC’s effectiveness may be dependent on estrogen receptors and vary by BC subtype (Tao et al., 2021).